Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months

Size: px
Start display at page:

Download "Equitas Holding. Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months"

Transcription

1 Equitas Holding Absolute :REDUCE Relative : UNDERWEIGHT 1QFY18 Results: Est. ( ), Target ( ), Rating ( ) Regular Coverage 4% Downside in 14Months 2017Equirus All rights reserved Rating Information Price (Rs) 168 Target Price (Rs) 161 Target Date 30 th Sep 18 Target Set On 31 st Jul 17 Implied yrs of growth (ERE) 20 Fair Value (ERE) 161 Fair Value (DDM) Ind Benchmark Model Portfolio Position - Stock Information NA BANKEX Market Cap (Rs mn) 56,689 Free Float (%) % 52 Wk H/L (Rs) / Avg Daily Volume (1yr) 1,633,971 Avg Daily Value (1yr) 272 Equity Cap (Rs Mn) 3,384 Face Value (Rs) 10 Bloomberg Code EQUITAS IN Ownership Recent 3M 12M % Promoters 0.0 % 0.0 % 0.0 % DII 37.3 % 4.8 % 8.3% FII 16.0 % 6.3 % 4.5% Public 46.7 % % -12.8% Price % 1M% 3M% 12M% Absolute 11.7 % 0.8 % % Vs Industry 3.6 % % % UJJIVAN 4.4 % % % BHARATFIN 17.2 % 5.1 % -6.9 % Consolidated Quarterly EPS forecast Rs/Share 1Q 2Q 3Q 4Q EPS (17A) EPS (18E) Return ratios to take time to normalize; retain REDUCE Equitas Holding Ltd (EQUITAS) saw a 31% yoy decline in 1QFY18 PAT to Rs 156mn (EE Rs 226mn) on higher opex (+102% yoy) and provisions (+151% yoy), even as it booked Rs 601mn as PSLC fees. MFI disbursements (-57% yoy/-22% qoq) remained weak and in line with management strategy to reduce the MFI loan share to ~30% by FY18E (1QFY18: 42%). Asset quality remained stressed as PAR >0/>90 days stood at ~7%/~4.1% (vs. ~5.9%/~2.7%). First-month MFI collection efficiency declined further with Jun 17 collection at 94% (Mar 17: 94.4%). We pare FY18E/FY19E EPS as we build in higher opex expenses and reduce NII assumptions for FY18E. Maintain REDUCE with an ERoE-based Sep 18 TP of Rs 161 (Rs 171 earlier) set at 2.5/2.4 Sep 18/Mar 19 ABV of Rs 64/67. Weak disbursements lead to subdued 7% yoy AUM growth: EQUITAS reported gross AUM growth of 7% yoy/-2% qoq to Rs 70.4bn. While MFI disbursements declined 57% yoy, non-mfi disbursements were also modest at 20% yoy. The share of MFI/UCV/M-LAP in disbursements was at 33%/27%/20%. Deposit growth remained healthy at 19.6% qoq to Rs 22.6bn with retail TDs (<Rs 10mn) constituted ~35% of total deposits. CASA ratio stood at 26%/9% of total deposits/liabilities. Avg. balance per customer of CA/SA deposits was Rs 95k/Rs 48k. Higher opex, provisions drag down PAT: NII growth was subdued at 5.6% yoy/-2.5% qoq as NIM declined 70bps qoq on a change in the AUM mix and lower excess interest spreads on the securitized portfolio. EQUITAS sold PSLCs worth Rs 36bn and booked entire fee income of Rs 0.6bn during 1QFY18. The company has sold Rs 150mn by premium value of insurance products and has mobilized 6000 MF SIPs in 1QFY18. Opex increased by 102% yoy/21% qoq as branch and employee expenses remained elevated. GNPL ratio ~5% for both MFI/non-MFI loans: GNPA/NNPA ratios stood at 4.9%/2.4% (+138bps/+89bps qoq). Of total GNPAs of Rs 3bn, Rs 1.21bn were related to MFIs (~5%) and the rest Rs 1.79bn to the non-mfi book (~4.9%). UCV/M-LAP GNPLs stood at ~6.5%/~1.5%. Maharashtra contributes ~55% of MFI PAR>0. Only 25% of delinquent customers have been regular in re-paying recent installments. Management expects MFI collections to improve post the list of individuals eligible for waivers is released. Retain REDUCE with a Sep 18 TP of Rs 161: EQUITAS re-aligned its provisioning policy in line with RBI guidelines. Consequently, we trim our provision estimates for FY18E/FY19E. Given better-than-expected deposit and CASA traction, we raise FY19E NII estimates by 3% while lowering FY18E NII estimates by 8% on a change in the AUM mix in favor of lower-yielding loans. Maintain REDUCE with an ERoE based Sep 18 TP of Rs 161 (Rs 171 earlier). An improvement in MFI collections and faster breakeven of branches leading to a quicker recovery of profitability are the key risks. Financials Revised Estimates % Change FY18E FY19E FY18E FY19E NII 9,090 11, % 3.0% Provisions 989 1, % -37.0% PAT (Adj) 703 1, % -28.2% EPS (Rs.) % -28.8% Advances 70, , % 21.6% Deposits 38,105 64, % 59.1% Consolidated Financials Rs. Mn YE Mar FY17A FY18E FY19E FY20E Interest Income 14,423 15,175 17,346 22,072 Interest Expense 5,871 6,084 5,931 7,213 Net Interest Inc. 8,552 9,090 11,415 14,859 Other Income 1,511 2,269 1,913 2,027 Operating Exp 6,094 9,276 9,960 11,348 Provisions 1, ,088 1,546 PAT 1, ,482 2,595 Loan and Advances 58,289 70, , ,428 Deposits 18,857 38,105 64,047 89,983 Net Worth 22,309 23,011 24,493 27,088 NIM 10.6 % 9.6 % 10.3 % 10.4 % Prov/Avg Loan 2.7% 1.5% 1.3% 1.3% Rs Per Share FY17A FY18E FY19E FY20E EPS Adjusted EPS Book Value Adjusted BVPS DPS P/B (x) Adj P/B (x) Adj ROE (%) 8.9 % 3.1 % 6.2 % 10.1 % RoA (%) 2.0 % 0.7 % 1.3 % 1.7 % August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 1 of 13 Before reading this report, you must refer to the disclaimer on the last page.

2 Quarterly Results Table Particulars %Variation P&L Statement (Rsmn) 1QFY18 1QFY18E 1QFY17 4QFY17 % change vs Est % change y-y % change q-q Net interest income (NII) 2,158 2,259 2,044 2, % 5.6% -2.5% Other income % 258.7% 322.1% Total income 2,980 2,724 2,273 2, % 31.1% 23.7% Operating expenses 2,286 2,015 1,134 1, % 101.6% 21.0% Staff expenses 1,352 1, , % 79.7% 15.5% Other expenses % 144.8% 29.9% Operating profit , % -39.0% 33.6% Total provisions % 151.1% 7.5% Exceptional items Profit before tax % -73.7% 131.5% Tax % -72.3% 141.1% Profit after tax % -74.5% 125.9% Adjusted PAT % -74.5% 125.9% Balance sheet (Rs mn) 1QFY18 1QFY18E 1QFY17 4QFY17 % change vs Est % change y-y % change q-q Deposits 22,550 20,487-18, % % CASA 5,879-3, % Borrowings 42,771 43,556 41,518 46, % 3.0% -8.2% Advances 61,049 60,994 57,103 58, % 6.9% 4.7% Total gross AUMs 70,361 74,630 65,589 71, % 7.3% -2.0% Disbursement 10,550 13,910 10, % 1.8% MFI Disbursement 3,482 8,020 4, % -21.8% Non MFI Disbursement 7,069 5,890 5, % 19.7% Gross NPL (Rsmn) 3, , % 45.6% Net NPL (Rsmn) 1, , % 56.2% August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 2 of 14

3 Ratios (%) 1QFY18 1QFY18E 1QFY17 4QFY17 bp change y-y bp change q-q Profitability ratios Yield on Advances 20.2% 20.6% 20.2% Cost of Funds 9.2% 11.0% 9.7% NIM 9.1% 12.6% 9.8% RoaA 0.7% 3.7% 0.3% RoaE 2.8% 14.2% 1.2% -1, Asset Quality Gross NPL ratio 4.9% 1.6% 3.5% Net NPL ratio 2.4% 1.1% 1.5% Business & Other Ratios Cost-income ratio 76.7% 49.9% 78.4% 2, Non int. inc / Total income 27.6% 10.1% 8.1% 1,751 1,951 CASA 26.0% % CRAR 34.9% % Tier % % Source: Company, Equirus Sec August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 3 of 14

4 Exhibit 1:GNPA further deteriorated by 138bps qoq with higher GNPA of MFI Loans 6.0% Exhibit 3:CASA and term deposit growth showed good traction during 1QFY18 4.8% 4.9% 5.0% 4.4% 4.4% 4.9% 5.0% 4.0% 3.5% 3.0% 3.0% 2.5% 2.5% 2.5% 2.0% 1.6% 1.0% 0.3% 0.3% 0.3% 0.0% Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Source: Company Filings, Equirus Research Exhibit 2:Share of Microfinance AUM dropped from ~46% to ~42% qoq MF Non-MF Total 25.6% 9.0% 0.0% 4.6% 4.1% 4.2% 6.8% Source: Company Filings, Equirus Research 17.2% 28.6% Term Loan Refinance Debenture Sub Ordinated Debt Commercial Paper Unsecured Loan from Banks/FII CASA Term Deposit CBLO Exhibit 4:NIMs continues to decline lower share of MFI loans in the AUM mix and lower interest contribution from the securitized portfolio 2.0% 0.9% 0.2% 0.4% 0.2% 3.7% Microfinance 22.9% 27.7% Source: Company Filings, Equirus Research 42.0% UCV Micro LAP Housing Business Loan Agri Loan Gold Loan Small and Mid Corporate Loans Others Yield Funding Cost NIMs 30.0% 12.6% 25.0% 11.9% 11.8% 11.3% 11.2% 10.5% 10.0% 9.8% 9.1% 20.0% 15.0% 10.0% 5.0% 0.0% 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 Source: Company Filings, Equirus Research 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% August 1, 2017 Analyst: Rohan Mandora ( )/Ankit Choudhary Page 4 of 14

5 Exhibit 5:C/I ratio remained elevated at 77% due to rolling out of liability branches along with hiring spree 90.0% 80.0% 70.0% 60.0% 50.0% 47.6% 50.2% 53.0% 53.7% 54.6% 49.9% 58.6% 63.1% 80.4% 76.7% Exhibit 7: Average SA balances in rural/semi-urban locations is ~Rs 12,200 FY16 Source: RBI, Equirus Research No. of SA accounts (mn) Amount (Rsbn) Avg SA Balance (Rs) Rural 515 4,962 9,640 Semi-Urban 404 6,256 15,487 Urban 223 6,590 29,580 Metropolitan 209 8,876 42,452 All India 1,351 26,684 19, % 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 Source: Company Filings, Equirus Research Exhibit 6:PAR has increased to ~7% 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 POS (Rs Mn) PAR 8.0% 7.0% 6.0% 5.0% 4.0% 3.0% 2.0% 1.0% - Sep '16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Jun % Source: Company Filings, Equirus Research August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 5 of 14

6 Concall highlights Equitas Holdings Absolute REDUCE Relative UNDERWEIGHT 4% Downside in 14 Months SFB transition update Challenges faced by Equitas are: 1. Leveraging new branch infrastructure and incurred costs for CASA origination and cross-sell income 2. Scaling up new asset products with stable asset quality 3. Leveraging physical infrastructure and staff for new products 4. Getting MFI business back to normal levels The company added 51 new branches during 1QFY18. Of these, 35 branches are ready for operations with employees already recruited and technology expenses incurred. Costs incurred for branch expansion are in line with management estimates. New asset products have been launched from ~130 branches. Training of employees on newer products would not entail significant costs as many products (agri loans, M-LAP) are cross-sold to existing MFI customers. Also, ~60% of M-LAP customers are MFI customers. The overlap of newer products with MFI customers is much lower. Infrastructure cost per branch is Rs 3.5mn. Yearly operating costs including salary and rentals stand at Rs 4.5-5mn/ branch. MFI business Of Rs 2.08bn of PAR in microfinance, ~Rs 370mn is in securitized loans. About ~Rs 700mn of provisions are outstanding against MFI loans. Collection efficiency in MFI loans disbursed post 1 Jan 17 was at 99.8%. All (100%) disbursements post demonetization were through bank accounts During 1QFY18, EQUITAS changed its MFI provision in line with RBI guidelines. Out of the overdue customers, ~35% have paid at least one installment in the past two or three months. As observed in the state of Uttar Pradesh (UP) by other MFIs, a recovery from overdue Maharashtra customers is likely once the list of individuals eligible for loan waivers is released. Losses in MFI securitized book will adversely impact NIMs due to lower excess income spread book by EQUITAS. Non-MFI business EQUITAS sold Rs 36bn of PSLCs during the quarter. The entire fee income of Rs 600mn from PSLC sale was booked in 1QFY18 and has not been amortized over the year. As on date, there is no further headroom for additional sale of PSLCs. However, there could be additional opportunity to sell PSLCs based on fresh disbursements done over FY18E, over and above PSL requirements. Business loan/agri/gold loans have taken off well and now constitute ~3.5% of the AUM. Share of CV/M-LAP in incremental disbursements is ~27%/20% Due to GST, there is a slowdown in MSME and business loans amid confusion and lack of clarity among borrowers. Currently EQUITAS is only disbursing agri loans to farmers with land between 1-5 acres. It will roll out products for farmers with land above five acres soon. About 70% of retail borrowers also are savings account customers. NIMs declined due to lower earnings on the securitized portfolio and change in mix of AUM. More than 30-40bps of NIM decline was due to lower Excess interest Spread (from securitization transaction) Asset quality GNPA is the non-mfi book primarily stemmed from UCV and M-LAP. GNPAs for UCV/M-LAP stood at ~6.5%/~1%. EQUITAS expects a decline in non-mfi GNPLs going ahead as the product mix will include higher share of larger-ticket secured loans to better quality customers, albeit at a lower interest rates. Unsold vehicle stock is shown as NPA in Bank. Guidance The company expects FY18 ROE to be lower than FY17 as FY18 includes the full impact of transition towards SFB. Management guides for ROA and ROE of 2-2.5% and 16-20% in the next 3-5 years. EQUITAS expects the MFI book to be below 30% by FY18 from current levels of 42%. Management is keen on building a stable book that is insulated from the external environment. EQUITAS expects to serve 10-11mn households by 2025 vs mn households currently. August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 6 of 14

7 Exhibit 7: ROE-ROA Tree Analysis Particulars (Rsmn) FY17A FY18E FY19E FY20E Yield on Gross AUMs 21.7% 20.1% 19.0% 18.6% Yield on Investments 6.8% 6.8% 6.8% 6.8% Cost of Funds 10.5% 8.9% 8.0% 7.8% Net Interest Margin (incl off balance sheet) 10.6% 9.6% 10.3% 10.4% Advances (A) 58,289 70, , ,428 Investments (B) 7,731 15,113 16,467 22,835 Cash In Hand & Balance with RBI [C] 10,651 4,267 3,875 5,373 Securitization (D) 13,471 8, IEA (on & off balance sheet) (E = A+B+C+D) 90,142 98, , ,636 Average IEA (on & off balance sheet) (F) 80,502 94, , ,192 NII/Avg IEA(on &off balance sheet) 10.6% 9.6% 10.3% 10.4% IEA (on balance sheet) (G = A+B+C) 76,671 89, , ,636 AvgInt Earning Asset (on balance sheet) (H) 68,481 83, , ,192 Asset multiplier (F/H) NII/AvgInt Earning Asset (on balance sheet) 12.5% 10.9% 10.7% 10.4% Non IntInc/AvgInt Earning Assets 2.2% 2.7% 1.8% 1.4% Total Income/AvgInt Earning Assets 14.7% 13.7% 12.5% 11.8% Op. Costs/AvgInt Earning Assets 8.9% 11.2% 9.3% 7.9% PPI/AvgInt Earning Assets 5.8% 2.5% 3.2% 3.9% Provisions/AvgInt Earning Assets 2.1% 1.2% 1.0% 1.1% Taxes/AvgInt Earning Assets 1.3% 0.5% 0.7% 1.0% Return on AvgInt Earning Assets 2.3% 0.8% 1.4% 1.8% Adj Return on AvgInt Earning Assets 2.3% 0.8% 1.4% 1.8% Productivity (Avg IEA/Avg Total Assets) Return on Average Total Assets 2.0% 0.7% 1.3% 1.7% Leverage (Avg Total Assets/Avg Equity) Return on Average Equity 8.9% 3.1% 6.2% 10.1% Source: Company Filings, Equirus Research August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 7 of 14

8 Company Snapshot How we differ from Consensus Equirus Consensus % Diff Comment EPS NII + Other Inc PAT (adj.) FY18E % FY19E % FY18E 11,360 11,970-5 % FY19E 13,328 14,557-8 % FY18E 703 1, % FY19E 1,482 2, % We expect consensus estimates to be revised Our Key Investment arguments: The company is in a migration phase to SFB and is adversely impacted due to demonetization. We expect near term opex and credit cost expenses to remain elevated and expect ROE to improve to double digit only by FY20. Key Assumptions 2016A 2017A 2018E 2019E 2020E Yields on Gross AUMs (%) 20.5% 21.7% 20.1% 19.0% 18.6% Yield on Investments (%) 0.0% 6.8% 6.8% 6.8% 6.8% Cost of Funds (%) 11.3% 10.5% 8.9% 8.0% 7.8% NIMs (%) 10.2% 10.6% 9.6% 10.3% 10.4% NII Growth (%) 53.2% 42.3% 6.3% 25.6% 30.2% PPI Growth (%) 49.2% 24.3% -47.5% 61.6% 64.5% Provision/Avg Loans(%) 1.4% 2.7% 1.5% 1.3% 1.3% PAT Growth (%) 56.8% -4.7% -55.9% 110.9% 75.1% Advances Growth (%) 46.3% 15.0% 20.5% 47.3% 30.0% Deposit Growth (%) NA NA 102.1% 68.1% 40.5% Key Risks: Improvement in MFI collection efficiency, Faster breakeven of branches leading to quicker recovery of profitability. Key Triggers: Early breakeven of branches, healthy recoveries from stressed portfolio Sensitivity to Key Variables % Change % Impact on EPS Net Interest Income 10 % 0.6 % Provisioning Costs 10 % -6.4 % ERoE Valuations & Assumptions Rf Ke Term. Growth RoE in Terminal Yr 6.8 % 13.4 % 5.0 % 18.1 % - FY18E FY19-22E FY23-27E FY28-37E PAT Growth % 43.3 % 20.7 % 18.0 % Dividend Payout (%) 0.0 % 0.0 % 10.0 % 10.0 % BV growth 3.1% 12.6% 16.2% 17.5% RoE (%) 3.1 % 10.4 % 16.2 % 17.8 % - Years of strong growth Valuation as on date (Rs) Valuation as of Sep Our Sep 18 TP of Rs.161 (vs.sep 18 TP of Rs. 171 earlier) based on EroE basis. Our TP corresponds to 2.5/2.4 Sep 18/Mar 19 ABV of Rs. 64/68. Company Description: Incorporated in 2005, Equitas Financial Services Ltd (Equitas) is a Tamil Nadu headquartered microfinance company which has been granted a small banking license by RBI in The company offers Microfinance loans, housing loans, Used Commercial Vehicle (UCV) loans and MSE loans. As on Mar 17, the firm has a distribution network of 610 branches across 14 states/uts Comparable valuation Mkt Cap Price Target EPS P/E BPS P/B RoE Div Yield Company Reco. CMP Rs. Mn. Target Date FY17A FY18E FY19E FY17A FY18E FY19E FY17A FY18E FY17A FY18E FY19E FY17A FY18E EQUITAS REDUCE , Sep ' % 3 % 6 % 0.0 % 0.0 % UJJIVAN REDUCE , Sep % 8 % 12 % 0.2 % 0.2 % BHAFIN NR ,613 NR NR % 17 % 22 % 0.0 % 0.8 % August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 8 of 14

9 Consolidated Quarterly Earnings Forecast and Key Drivers Rs in Mn 1Q17A 2Q17A 3Q17A 4Q17A 1Q18A 2Q18E 3Q18E 4Q18E 1Q19E 2Q19E 3Q19E 4Q19E FY17A FY18A FY19E FY20E Interest Income 3,259 3,560 3,822 3,782 3,744 3,770 3,789 3,872 3,979 4,214 4,450 4,703 14,423 15,175 17,346 22,072 Interest Expense 1,215 1,556 1,531 1,568 1,586 1,506 1,517 1,474 1,464 1,455 1,488 1,523 5,871 6,084 5,931 7,213 Net Interest Income 2,044 2,004 2,291 2,214 2,158 2,264 2,271 2,398 2,515 2,758 2,962 3,179 8,552 9,090 11,415 14,859 Non Interest Income ,511 2,269 1,913 2,027 Total Income 2,273 2,673 2,709 2,409 2,980 2,736 2,750 2,894 3,031 3,177 3,448 3,673 10,063 11,360 13,328 16,886 Operating and Other Expenses 1,134 1,408 1,663 1,889 2,286 2,308 2,330 2,353 2,440 2,473 2,507 2,541 6,094 9,276 9,960 11,348 Staff Cost ,118 1,171 1,352 1,366 1,379 1,393 1,463 1,478 1,492 1,507 3,961 5,491 5,940 6,831 Other Operating Expenses ,134 2,984 3,311 4,517 Pre-Provision Income 1,139 1,265 1, ,131 3,968 2,083 3,367 5,538 Provisions and Write-offs , ,088 1,546 PBT ,515 1,095 2,280 3,992 TAX ,397 Extraordinary PAT , ,482 2,595 EPS Key Drivers YoA 20.6% 20.9% 21.4% 21.1% 21.1% 21.0% 20.3% 20.0% 19.5% 19.3% 19.0% 18.8% 21.7% 20.1% 19.0% 18.6% YoI 0.0 % 0.0 % 6.8 % 6.8 % 0.0 % 6.8 % 6.8 % 6.8 % 6.8 % 6.8 % 6.8 % 6.8 % 6.8 % 7.1 % 6.7 % 6.8 % CoF 11.0 % 12.1 % 10.2 % 10.1 % 10.5 % 9.7 % 9.0 % 8.7 % 8.3 % 8.9 % 8.2 % 8.1 % 10.5 % 8.9 % 8.0 % 7.8 % NIM 11.5 % 9.6 % 9.7 % 9.1 % 9.2 % 9.4 % 9.6 % 9.9 % 10.0 % 10.4 % 10.5 % 10.6 % 10.6 % 9.6 % 10.3 % 10.4 % C/I Ratio 50 % 53 % 61 % 78 % 77 % 84 % 85 % 81 % 80 % 78 % 73 % 69 % 61 % 82 % 75 % 67 % CD Ratio NA 5197% 805% 309% 271% 238% 213% 193% 184% 176% 168% 161% 309% 184% 161% 149% Non-Interest Income/ Total Income 10.1 % 25.0 % 15.4 % 8.1 % 27.6 % 17.3 % 17.4 % 17.1 % 17.0 % 13.2 % 14.1 % 13.4 % 15.0 % 20.0 % 14.4 % 12.0 % ROA 3.7 % 2.3 % 2.0 % 0.3 % 0.7 % 0.5 % 0.7 % 1.0 % 0.9 % 1.0 % 1.4 % 1.6 % 2.0 % 0.7 % 1.3 % 1.7 % ROE 14.2 % 8.7 % 8.2 % 1.2 % 2.8 % 2.1 % 3.1 % 4.4 % 3.9 % 4.9 % 7.2 % 8.9 % 8.9 % 3.1 % 6.2 % 10.1 % Sequential Growth (%) NII 20.0 % -1.9 % 14.3 % -3.3 % -2.5 % 4.9 % 0.3 % 5.6 % 4.9 % 9.7 % 7.4 % 7.3 % TI 18.1 % 17.6 % 1.3 % % 23.7 % -8.2 % 0.5 % 5.2 % 4.7 % 4.8 % 8.5 % 6.5 % PPI 30.3 % 11.0 % % % 33.6 % % -2.0 % 28.9 % 9.3 % 19.1 % 33.7 % 20.2 % Provisions and Write-offs 20 % 200 % -36 % 21 % 7 % -45 % -39 % 4 % 58 % 7 % 7 % 7 % PAT 31 % -24 % -3 % -85 % 126 % -23 % 46 % 43 % -10 % 28 % 50 % 26 % EPS 8 % -28 % -2 % -85 % 125 % -11% -2% 1% -15% -1% 0% 4% Advances 13 % -1 % 4 % -1 % 5 % 9 % 5 % 5 % 9 % 7 % 13 % 7 % Deposits % 158 % 20 % 24 % 17 % 17 % 15 % 12 % 18 % 12 % Total Business 5 % -1 % 7 % 6 % 6 % 6 % 6 % 6 % 5 % 6 % 6 % 8 % Yearly Growth (%) NII 62 % 40 % 47 % 30 % 6 % 13 % -1 % 8 % 17 % 22 % 30 % 33 % 42 % 6 % 26 % 30 % TI 52 % 66 % 53 % 25 % 31 % 2 % 2 % 20 % 2 % 16 % 25 % 27 % 48 % 13 % 17 % 27 % PPI 53 % 67 % 28 % -41 % -39 % -66 % -60 % 4 % -15 % 64 % 124 % 109 % 24 % -48 % 62 % 64 % Provisions and Write-offs 7 % 283 % 138 % 181 % 151 % -54 % -56 % -62 % -44 % 8 % 88 % 94 % 146 % -32 % 10 % 42 % PAT 64 % 16 % 4 % -85 % -74 % -74 % -61 % 263 % 44 % 139 % 144 % 115 % -5 % -56 % 111 % 75 % EPS 33.8% -8.8% -18.1% -88.4% -75.8% -74.1% -61.3% 261.7% 44.2% 139.1% 144.3% 115.4% -24.2% -56.8% 110.9% 75.1% Advances 42 % 27 % 17 % 15 % 7 % 18 % 18 % 26 % 31 % 29 % 39 % 41 % 15 % 20 % 47 % 30 % Deposits ,467 % 347 % 102 % 94 % 75 % 76 % 68 % % 68 % 40 % Total Business 42 % 29 % 32 % 52 % 46 % 64 % 55 % 45 % 48 % 42 % 51 % 50 % 52 % 40 % 55 % 34 % August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 9 of 14

10 Consolidated Financials Equitas Holdings Absolute REDUCE Relative UNDERWEIGHT 4% Downside in 14 Months P&L FY17A FY18A FY19E FY20E Balance Sheet (Rs mn) FY17A FY18A FY19E FY20E FY17A FY18A FY19E FY20E Interest Income 14,423 15,175 17,346 22,072 Capital 3,381 3,381 3,381 3,381 Asset Quality Interest Expense 5,871 6,084 5,931 7,213 Reserves and Surplus 18,928 19,631 21,112 23,707 Gross NPA (Rs mn) 2,060 2,954 3,696 4,494 Net Interest Income 8,552 9,090 11,415 14,859 Deposits 18,857 38,105 64,047 89,983 Gross NPA (%) 3.5% 4.2% 3.6% 3.3% % Growth 42.3% 6.3% 25.6% 30.2% Borrowings 46,572 33,015 13,443 17,476 Net NPA (Rs mn) 1,050 1,505 1,884 2,291 Other Income 1,511 2,269 1,913 2,027 Other Liabilities & Provisions 6,698 3,984 33,387 41,875 Net NPA (%) 1.5% 2.1% 1.8% 1.7% Total Income 10,063 11,360 13,328 16,886 Total liabilities 94,435 98, , ,422 % coverage of NPA 49.0% 49.0% 49.0% 49.0% Employees Expenses 3,961 5,491 5,940 6,831 Cash & Cash Equivalent 10,651 4,267 3,875 5,373 Other Op. Expenses 2,134 2,984 3,311 4,517 Investments 7,731 15,113 16,467 22,835 Business Ratios Total Expenses 6,094 9,276 9,960 11,348 Advances 58,289 70, , ,428 Credit / Borrowing(%) 89.1% 98.7% 133.4% 125.1% Operating Profit 1, ,482 2,595 Int Earnings Assets 66,020 85, , ,263 Investment / Deposit (%) 41.0% 39.7% 25.7% 25.4% % Growth 24.3% -47.5% 61.6% 64.5% Fixed Assets 3,288 5,589 8,384 10,061 RoaA (%) 2.0% 0.7% 1.3% 1.7% Tax ,397 Other Assets 14,476 2,935 3,239 3,725 RoE (%) 8.9% 3.1% 6.2% 10.1% Total Provisions 1, , ,545.9 Total assets 94,435 98, , ,422 Dividend Yield (%) 0.0% 0.0% 0.0% 0.0% Net Profit 1, , ,594.8 % Growth 45.1% 3.9% 38.0% 30.3% % Growth -4.7% -55.9% 110.9% 75.1% Key assumptions Growth (%) Earnings Ratios Borrowings Total IncGro 48.2% 12.9% 17.3% 26.7% IntInc/Avg asset (%) 18.1% 15.8% 14.9% 14.2% Avg Borrowing gro (%) 39.7% 8.7% 9.0% 38.7% Total Exp Gr 69.4% 52.2% 7.4% 13.9% Int Exp./Avg. assets (%) 7.4 % 6.3 % 5.1 % 4.6 % Avg cost of funds (%) 10.5% 8.9% 8.0% 7.8% Provision Growth 145.9% -32.0% 10.0% 42.1% NIM (%) - computed 10.6 % 9.6 % 10.3 % 10.4 % Advances Int. exp/ Int earned (%) 40.7 % 40.1 % 34.2 % 32.7 % Avg. advgro (%) 15.0% 20.5% 47.3% 30.0% Per Share Data Oth. Inc./ Tot. Inc. (%) 15.0 % 20.0 % 14.4 % 12.0 % Avg yield on AUM (%) 21.7% 20.1% 19.0% 18.6% BVPS Rs Staff exp/total opt. exp (%) 65.0 % 59.2 % 59.6 % 60.2 % Investments Adj. BVPS, Rs Cost/ Income Ratio (%) 60.6 % 81.7 % 74.7 % 67.2 % Avg. investmtgro (%) % 95.5% 9.0% 38.7% Price/ Adj. BV Prov./ Operating Profit (%) 36.6 % 47.5 % 32.3 % 27.9 % Avg. YoI (%) 6.8% 6.8% 6.8% 6.8% EPS, Rs P/E Ratio August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 10 of 14

11 Historical Consolidated Financials P&L FY14A FY15A FY16A FY17A Balance Sheet FY14A FY15A FY16A FY17A FY14A FY15A FY16A FY17A Interest Income 4,355 6,868 10,368 14,423 Capital 730 2,689 2,699 3,381 Asset Quality Interest Expense 1,895 2,947 4,360 5,871 Reserves and Surplus 6,690 9,019 10,714 18,928 Gross NPA (Rs mn) ,060 Net Interest Income 2,460 3,921 6,008 8,552 Deposits ,857 Gross NPA (%) 0.7% 1.1% 1.3% 3.5% % Growth 67.4% 59.4% 53.2% 42.3% Borrowings 18,492 30,322 46,833 46,572 Net NPA (Rs mn) ,050 Other Income ,511 Other Liabilities 1,604 2,619 4,819 6,698 Net NPA (%) 0.6% 0.8% 0.9% 1.5% Total Income 2,940 4,612 6,789 10,063 Total liabilities 27,516 44,649 65,065 94,435 % coverage of NPA 16.4% 25.7% 29.9% 49.0% Employees Expenses 1,003 1,551 2,338 3,961 Cash & Cash Equivalent 4,147 5,574 9,470 10,651 Other Op. Expenses ,259 2,134 Investments 34 1, ,731 Business Ratios Total Expenses 1,618 2,472 3,597 6,094 Advances 21,232 34,646 50,702 58,289 Credit / Borrowing 114.8% 114.3% 108.3% 89.1% Operating Profit 1,322 2,140 3,192 3,968 Int Earnings Assets 21,266 36,401 50,821 66,020 Investment/Deposit NA NA NA 41.0% % Growth 166.8% 61.9% 49.2% 24.3% Fixed Assets ,288 RoaA (%) 3.2% 3.0% 3.0% 2.0% Tax Other Assets 1,831 2,206 4,117 14,476 RoE (%) 12.2% 11.1% 13.3% 8.9% Total Provisions ,453.3 Total assets 27,516 44,649 65,065 94,435 Dividend Yield (%) 0.0% 0.0% 0.0% 0.0% Net Profit , , ,593.1 % Growth 48.4% 62.3% 45.7% 45.1% % Growth 126.8% 43.4% 56.8% -4.7% Key assumptions Growth (%) Earnings Ratios Borrowings Total Income Gr 67.5% 56.9% 47.2% 48.2% Int Inc./Avg. Assets 18.9% 19.0% 18.9% 18.1% Avg Borrowing growth 45.1% 64.0% 54.5% 39.7% Total Exp Gr 28.4% 52.8% 45.5% 69.4% Int Exp./Avg. assets 8.2% 8.2% 7.9% 7.4% Avg cost of funds (%) 11.8% 11.6% 11.3% 10.5% Provision Growth 106.3% 174.3% 17.2% 145.9% NIM (%) - computed 10.2% 10.3% 10.2% 10.6% Advances Int. exp/ Int earned 43.5% 42.9% 42.0% 40.7% Avg. advances growth 75.0% 63.2% 46.3% 15.0% Per Share Data Oth. Inc./ Tot. Inc. 16.3% 15.0% 11.5% 15.0% Avg yield on AUM (%) 21.9% 21.1% 20.5% 21.7% BVPS Staff exp/opex 62.0% 62.7% 65.0% 65.0% Investments Adj. BVPS, Rs Cost/ Income Ratio 55.0% 53.6% 53.0% 60.6% Avg. investments Gr -13.8% % -93.2% % Price/ Adj. BVPS Prov./ Op Profit 13.9% 23.6% 18.5% 36.6% Avg. YoI 0.0% 0.0% 0.0% 6.8% EPS, Rs P/E Ratio August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 11 of 14

12 Equirus Securities Research Analysts Sector/Industry Equity Sales Abhishek Shindadkar IT Services VishadTurakhia Ashutosh Tiwari Auto, Metals & Mining Subham Sinha Depesh Kashyap Mid-Caps SwetaSheth Devam Modi Power & Infrastructure Viral Desai DhavalDama FMCG, Mid-Caps BinoyDharia Manoj Gori Consumer Durables Dealing Room Maulik Patel Oil and Gas Ashish Shah Praful Bohra Pharmaceuticals IleshSavla Rohan Mandora Banking & Financial Services Manoj Kejriwal Associates Dharmesh Mehta Ankit Choudhary SandipAmrutiya Ashdeep Kaur Compliance Officer Bharat Celly Jay Soni Harshit Patel Meet Chande ParvaSoni Pranav Mehta RonakSoni Samkit Shah ShreepalDoshi Vikas Jain Rating & Coverage Definitions: Absolute Rating LONG : Over the investment horizon, ATR >= Ke for companies with Free Float market cap >Rs 5 billion andatr>= 20% for rest of the companies ADD: ATR >= 5% but less than Ke over investment horizon REDUCE: ATR >= negative 10% but <5% over investment horizon SHORT: ATR < negative 10% over investment horizon Relative Rating OVERWEIGHT: Likely to outperform the benchmark by at least 5% over investment horizon BENCHMARK: likely to perform in line with the benchmark UNDERWEIGHT: likely to under-perform the benchmark by at least 5% over investment horizon Investment Horizon Investment Horizon is set at a minimum 3 months to maximum 18 months with target date falling on last day of a calendar quarter. Lite vs. Regular Coverage vs. Spot Coverage We aim to keep our rating and estimates updated at least once a quarter for Regular Coverage stocks. Generally, we would have access to the company and we would maintain detailed financial model for Regular coverage companies. We intend to publish updates on Lite coverage stocks only an opportunistic basis and subject to our ability to contact the management. Our rating and estimates for Lite coverage stocks may not be current. Spot coverage is meant for one-off coverage of a specific company and in such cases, earnings forecast and target price are optional. Spot coverage is meant to stimulate discussion rather than provide a research opinion. Registered Office: Equirus Securities Private Limited Unit No. 1201, 12th Floor, C Wing, Marathon Futurex, N M Joshi Marg, Lower Parel, Mumbai Tel. No: +91 (0) Fax No:+91-(0) Corporate Office: 3rd floor, House No. 9, Magnet Corporate Park, Near Zydus Hospital, B/H Intas Sola Bridge, S.G. Highway Ahmedabad Gujarat Tel. No: +91 (0) Fax No:+91 (0) August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 12 of 14

13 2017 Equirus Securities Private Limited. All rights reserved. For Private Circulation only. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Equirus Securities Private Limited Analyst Certification We, Rohan Mandora/Ankit Choudhary, author to this report, hereby certify that all of the views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Disclosures Equirus Securities Private Limited (ESPL) having Corporate Identification Number U65993MH2007PTC is registered in India with Securities and Exchange Board of India (SEBI) as a trading member on the Capital Market (Reg. No. INB ), Futures & Options Segment (Reg. No.INF ) of the National Stock Exchange of India Ltd. (NSE) and on Cash Segment (Reg. No.INB ) of Bombay Stock Exchange Limited (BSE).ESPL is also registered with SEBI as Research Analyst under SEBI (Research Analyst) Regulations, 2014 (Reg. No. INH ), as a Portfolio Manager under SEBI (Portfolio Managers Regulations, 1993 (Reg. No.INP ) and as a Depository Participant of the Central Depository Services (India) Limited (Reg. No.IN-DP ). There are no disciplinary actions taken by any regulatory authority against ESPL. ESPL is a subsidiary of Equirus Capital Pvt. Ltd. (ECPL) which is registered with SEBI as Category I Merchant Banker and provides investment banking services including but not limited to merchant banking services, private equity, mergers & acquisitions and structured finance. As ESPL and its associates are engaged in various financial services business, it might have: - (a) received compensation (except in connection with the preparation of this report) from the subject company for investment banking or merchant banking or brokerage services in the past twelve months;(b) managed or co-managed public offering of securities for the subject company in the past twelve months; or (c) have received a mandate from the subject company; or (d) might have other financial, business or other interests in entities including the subject company (ies) mentioned in this Report. ESPL & its associates, their directors and employees may from time to time have positions or options in the company and buy or sell the securities of the company (ies) mentioned herein. ESPL and its associates collectively do not own (in their proprietary position) 1% or more of the equity securities of the subject company mentioned in the report as the last day of the month preceding the publication of the research report. ESPL or its Analyst or Associates did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ESPL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ESPL has not been engaged in market making activity for the subject company. The Research Analyst engaged in preparation of this Report:- (a) has not received any compensation from the subject company in the past twelve months; (b) has not managed or co-managed public offering of securities for the subject company in the past twelve months; (c) has not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) has not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) has not received any compensation or other benefits from the subject company or third party in connection with the research report; (f) might have served as an officer, director or employee of the subject company; (g) is not engaged in market making activity for the subject company. This document is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ESPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession of this document are required to inform themselves of, and to observe, such applicable restrictions. Please delete this document if you are not authorized to view the same. By reading this document you represent and warrant that you have full authority and all rights necessary to view and read this document without subjecting ESPL and affiliates to any registration or licensing requirement within such jurisdiction. This document has been prepared solely for information purpose and does not constitute a solicitation to any person to buy, sell or subscribe any security. ESPL or its affiliates are not soliciting any action based on this report. The information and opinions contained herein is from publicly available data or based on information obtained in good faith from sources believed to be reliable but ESPL provides no guarantee as to its accuracy or completeness. The information contained herein is as on date of this report, and is subject to change or modification and any such changes could impact our interpretation of relevant information contained herein. While we would endeavour to update the information herein on reasonable basis, ESPL and its affiliates, their directors and employees are under no obligation to update or keep the information current. Also there may be regulatory, compliance, or other reasons that may prevent ESPL and its group companies from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document including the merits and risks involved. This document is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. ESPL and its group companies, employees, directors and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it. ESPL/its affiliates do and seek to do business with companies covered in its research report. Thus, investors should be aware that the firm may have conflict of interest. August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 13 of 14

14 A graph of daily closing prices of securities is available at and (Choose a company from the list on the browser and select the three years period in the price chart). Disclosure of Interest statement for the subject Company Yes/No If Yes, nature of such interest Research Analyst or Relatives financial interest Research Analyst or Relatives actual/beneficial ownership of 1% or more Research Analyst or Relatives material conflict of interest No No No Disclaimer for U.S. Persons ESPL/its affiliates are not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Equirus is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the Acts ), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Equirus, including the products and services described herein are not available to or intended for U.S. persons. The information contained in this Report is not intended for any person who is a resident of the United States of America or a resident of any jurisdiction, the laws of which imposes prohibition on soliciting the securities business in that jurisdiction without going through the registration requirements and/ or prohibit the use of any information contained in this report. This Report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. August 1, 2017 Analyst: Rohan Mandora rohan.mandora@equirus.com ( )/Ankit Choudhary ankit.choudhary@equirus.com Page 14 of 14

Operating metrics stable, marginal uptick in slippages retain ADD

Operating metrics stable, marginal uptick in slippages retain ADD HDFC Bank Absolute :ADD Relative : Equal Weight 1QFY18 Result: Est. ( ), Target ( ), Rating ( ) Regular Coverage 7.6% ATR in 14 months Operating metrics stable, marginal uptick in slippages retain ADD

More information

Cholamandalam Finance

Cholamandalam Finance Cholamandalam Finance Absolute: LONG Relative : OverWeight 4QFY18 Result: Est. ( ), Target ( ), Rating( ) Regular Coverage 16% ATR in 11 months Strong all-round performance; momentum to continue ahead

More information

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD

Karur Vysya Bank. Absolute: ADD Relative: Benchmark BFSI. Asset quality to remain under pressure; retain ADD 2017EquirusAll rights reserved Rating Information Price (Rs) 111 Target Price (Rs) 122 Target Date 31 st Mar 19 Target Set On 31 st Jan 18 Implied yrs of growth (ERE) 20 Fair Value (ERE) 122 Fair Value

More information

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months

Cipla Ltd. Absolute : ADD Relative : Benchmark. 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 5% ATR in 16 Months 2018EquirusAll rights reserved Rating Information Price (Rs) 520 Target Price (Rs) 547 Target Date 30th Sep'19 Target Set On 22nd May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 543 Fair Value (DDM)

More information

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care

Domestic recovery on track, focus shifts on developing new brands upgrade to LONG on fair valuations Personal Care Bajaj Corp Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 13% ATR in 14 Months Domestic recovery on track, focus shifts on developing new brands

More information

Greaves Cotton Ltd. Standalone Estimate Revision:

Greaves Cotton Ltd. Standalone Estimate Revision: Greaves Cotton Ltd. Absolute : REDUCE Relative : UNDERWEIGHT 2QFY18 Result : Estimate (), TP (), Rating () Regular Coverage 2% Upside in 14months Changing industry dynamics to shake up key business verticals

More information

Solar Industries India

Solar Industries India Solar Industries India Absolute : ADD Relative : Overweight 4QFY18Result: Estimates(),PT(),Rating() Regular Coverage 9% ATR in 17 Months Strong 4Q led by international business; revise to ADD on earnings

More information

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs.

Bajaj Corp. Key risks: Lower than expected volume growth, increase in RM costs. 2017 Equirus All rights reserved Rating Information Price (Rs) 405 Target Price (Rs) 463 Target Date 30th Sep'18 Target Set On 13th July 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 388 Fair Value

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY18E FY19E FY18E FY19E 2017 Equirus All rights reserved Rating Information Price (Rs) 297 Target Price (Rs) 267 Target Date 31st Dec '18 Target Set On 17th Oct '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 270 Fair Value

More information

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE

Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Gujarat Gas Ltd. 2QFY18 Results: Estimate ( ), TP ( ), Rating ( ) Volumes in line but margins disappoint on one-offs - downgrade to REDUCE Regular Coverage Absolute: REDUCE Relative: Benchmark 5% Downside

More information

eclerx Services Ltd.

eclerx Services Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 1,327 Target Price (Rs) 1,264 Target Date 31st Mar '18 Target Set On 13th Jan '17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 1,174 Fair

More information

P&G Hygiene & Healthcare Ltd.

P&G Hygiene & Healthcare Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 8,015 Target Price (Rs) 8,965 Target Date 30 Jun 18 Target Set On 14 Jun 17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 8,965 Fair Value

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2017EquirusAll rights reserved Rating Information Price (Rs) 860 Target Price (Rs) 715 Target Date 31st Dec 18 Target Set On 07th Nov'17 Implied yrs of growth (DCF) 20 Fair Value (DCF) 824 Fair Value (DDM)

More information

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date

DB Corp Equirus All rights reserved Rating Information Price (Rs) 375 Target Price (Rs) 480 Target Date DB Corp Absolute : LONG Relative : Overweight 1QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 27% ATR in 14 Months Decent start to FY18, growth to accelerate in second half; retain LONG Media

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 1,980 Target Price (Rs) 2,312 Target Date 30th Jun'17 Target Set On 5th May'16 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,215 Fair

More information

Tata Consultancy Services

Tata Consultancy Services 2017 Equirus All rights reserved Rating Information Price (Rs) 2,446 Target Price (Rs) 2,434 Target Date 30th Sep '18 Target Set On 14th July 17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,630 Fair

More information

Lupin Ltd. Pharmaceuticals

Lupin Ltd. Pharmaceuticals 2018 Equirus All rights reserved Rating Information Price (Rs) 751 Target Price (Rs) 759 Target Date 31st Mar 19 Target Set On 15th May'18 Implied yrs of growth (DCF) 20 Fair Value (DCF) 708 Fair Value

More information

Maruti Suzuki India Limited

Maruti Suzuki India Limited Maruti Suzuki India Limited Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate (),PT (), Rating () Regular Coverage 13% ATR in 14 Months Margins impacted by one-offs, to normalize from 1QFY19-

More information

Torrent Power Limited

Torrent Power Limited Absolute : ADD Torrent Power Limited Relative : Overweight 2QFY18 Update: Estimate ( ), TP ( ), Rating ( ) Spot Coverage 7% ATR in 9 months Steady cash generation to continue; higher demand key to swing

More information

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11.

TeamLease Services. Ownership Recent 3M 12M Promoters 40.8 % 0.0 % -2.4 % DII 5.7 % 0.8 % -9.1 % FII 43.9 % 3.6 % 22.8 % Public 9.6 % -4.3 % -11. TeamLease Services Absolute: LONG Relative: Overweight 2QFY19 Result: Est. ( ), PT ( ), Rating ( ) Regular Coverage 12% ATR in 17 months One step forward; Upgrade to LONG as valuations turn reasonable

More information

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E

Wipro Ltd. Change in estimates: Revised Estimates % Change FY19E FY20E FY19E FY20E 2018 Equirus All rights reserved Rating Information Price (Rs) 288 Target Price (Rs) 290 Target Date 31st Mar '19 Target Set On 25th Apr '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 253 Fair Value

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 996 Target Price (Rs) 1,45 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 746 Fair Value (DDM) 1,43 Ind Benchmark

More information

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%)

Britannia Industries. Change in Estimates: Chg (%) FY17E Chg (%) 2016 Equirus All rights reserved Rating Information Price (Rs) 2,634 Target Price (Rs) 3,546 Target Date 31 st Mar'17 Target Set On 11th Feb'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 2,292 Fair

More information

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date

Jagran Prakashan Ltd. 2017EquirusAll rights reserved Rating Information Price (Rs) 173 Target Price (Rs) 200 Target Date Jagran Prakashan Ltd Absolute : LONG Relative : Overweight 3QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 15% ATR in 14 Months Weak quarter but green shoots of recovery emerging - maintain

More information

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research Continuing to grow strong May 07, 2018 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Shweta Daptardar shwetadaptardar@plindia.com / +91 22

More information

Fiem Industries Limited

Fiem Industries Limited Fiem Industries Limited Absolute: LONG Relative: Overweight 1QFY19 Result: Estimate ( ), PT ( ), Rating ( ) Regular Coverage 85% ATR in 11 Months LED benefit visible in Sales growth, margin should normalize

More information

LIC Housing Finance. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research High prepayment remains a drag; earnings momentum to sustain April 20, 2016 Nitin Kumar nitinkumar@plindia.com / +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves

Strong sales momentum continues, however margins continue to remain at lower levels. Retain TRADE until clarity on margin improves 2016 Equirus All rights reserved Rating Information Price (Rs) 384 Target Price (Rs) 398 Target Date 30thSept 17 Target Set On 31stJuly'16 Implied yrs of growth (DCF) 20 Fair Value (DCF) 328 Fair Value

More information

PSP Projects Limited SDB Project: A Marvel In The Making!

PSP Projects Limited SDB Project: A Marvel In The Making! S 2018 Equirus All rights reserved PSP Projects Limited SDB Project: A Marvel In The Making! Site Visit We recently visited PSP s Surat Diamond Bourse (SDB) project to get an update on its progress and

More information

Pokarna Ltd. Change in Estimates:

Pokarna Ltd. Change in Estimates: Pokarna Ltd. Absolute : LONG Relative : Overweight 3QFY16 Result : Estimate ( ), TP ( ), Rating ( ) Regular Coverage 57% ATR in 14 Months Stellar performance continues; Retain LONG as valuations are mouthwatering

More information

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

LIC Housing Finance. Stable performance. Source: Company Data; PL Research Stable performance October 21, 2016 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 Rating

More information

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY : price: ABV: How does our one year outlook change? Remains a idea in the SFB space owing to a well-diversified product profile, prudence in approaching the MFI space marked by the lowest ticket size amongst

More information

Sterlite Technologies Ltd.

Sterlite Technologies Ltd. 218 Equirus All rights reserved Rating Information Price (Rs) 336 Target Price (Rs) 41 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 441 Fair Value (DDM) 99 Ind Benchmark Model

More information

LIC Housing Finance. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research Strong performance, but loan growth key to sustainability in earnings July 18, 2016 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah

More information

Financial summary. Year

Financial summary. Year : price: ABV: How does our one year outlook change? We retain our positive outlook on KVB, led by an improving margin profile and cost containment kicking in, while our key thesis - a proven sole banking

More information

Punjab National Bank

Punjab National Bank Slippages remain high despite high recoveries May 22, 2017 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 657 Target Price (Rs) 653 Target Date 30th Sep '18 Target Set On 23rd July 17 Implied yrs of growth (DCF) 5 Fair Value (DCF) 793 Fair Value

More information

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone) Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 Sep-18 Jan-19 Q3FY2019 Result Update Banking Jan 22, 2019 HDFC Bank Performance Highlights BUY CMP `2,145 Target Price `2,500 Particulars (` cr)

More information

Punjab National Bank

Punjab National Bank Steady on all fronts February 07, 2018 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91 22 66322258 Rating

More information

DCB Bank Ltd. 1 P a g e

DCB Bank Ltd. 1 P a g e 4 Recommendation HOLD Another strong quarter CMP (16/04/2015) Rs. 120 Target Price Rs. 140 Sector Stock Details Banking BSE Code 532772 NSE Code Bloomberg Code DCB DEVB IN Market Cap (Rs cr) 3383 Free

More information

IDFC Bank. Source: Company Data; PL Research

IDFC Bank. Source: Company Data; PL Research Earnings led by large treasury gains; core performance weak July 28, 2017 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com

More information

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector 1QFY218 Result Update Banking August 2, 217 Federal Bank Performance Highlights Particulars (` cr) 1QFY18 4QFY17 % chg (qoq) 1QFY17 % chg (yoy) NII 8.7 842.4 (5.) 692.7 15.6 Pre-prov. profit 557.9 549.2

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. Kajaria Ceramics Ltd. Absolute: LONG Relative: Benchmark 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 11% ATR in 17 months 2018 Equirus All rights reserved Rating Information Price

More information

Apex Frozen Foods Ltd

Apex Frozen Foods Ltd Apex Frozen Foods Ltd Absolute : LONG Relative : Overweight 2QFY19 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 53% ATR in 14 Months Valuations attractive even on conservative guidance maintain

More information

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017 1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)

More information

3,746 2,551 3, NIM

3,746 2,551 3, NIM 4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or

More information

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)

More information

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG

Margin disappointment likely quarter-specific; mid/long-term prospects intact retain LONG Finolex Cables Ltd. Absolute : LONG Relative : Overweight 2QFY19 Results: Estimate( ), TP( ),Rating( ) Regular Coverage 18% ATR in 17 months Margin disappointment likely quarter-specific; mid/long-term

More information

HDFC Bank (HDFCB IN) Continue to perform strong

HDFC Bank (HDFCB IN) Continue to perform strong INSTITUTIONAL EQUITY RESEARCH HDFC Bank (HDFCB IN) Continue to perform strong INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 Earnings were in line with estimate. NII growth at 22% (vs expectation

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,284 Target Price (Rs) 1,449 Target Date Minda Industries Absolute : ADD Relative: Overweight 4QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 10% ATR in 16 Months Earnings growth momentum to continue, strong play on premiumization

More information

93,707 77,814 90, NIM

93,707 77,814 90, NIM 1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven

More information

HDFC Bank. In line results; loan growth holding nicely. Source: Company Data; PL Research

HDFC Bank. In line results; loan growth holding nicely. Source: Company Data; PL Research In line results; loan growth holding nicely February 14, 2015 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating BUY Price Rs1,066 Target Price

More information

Gujarat Ambuja Exports

Gujarat Ambuja Exports Gujarat Ambuja Exports Absolute : LONG Relative : Overweight 4QFY18 Result: Estimate ( ), TP ( ), Rating ( ) Regular Coverage 31% ATR in 13 Months Focus shifts to profitable growth maintain LONG Agricultural

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 Q3FY2019 Result Update Banking Feb 15, 2019 ICICI Bank Performance Highlights Particulars (` cr) Q3FY19 Q2FY19 % chg

More information

Punjab National Bank

Punjab National Bank Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 India Research Banking November 09, 2015 QUARTERLY REVIEW Bloomberg: PNB IN Reuters: PNBK.BO SELL Asset quality improves but recovery

More information

Punjab National Bank

Punjab National Bank May-15 Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Q4FY16 Result Update Asset quality showing no respite May 18, 2016 Nitin Kumar nitinkumar@plindia.com / +91-22-66322236 Pritesh Bumb priteshbumb@plindia.com

More information

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY 3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &

More information

Wipro Ltd. Change in estimates:

Wipro Ltd. Change in estimates: 2018EquirusAll rights reserved Rating Information Price (Rs) 307 Target Price (Rs) 329 Target Date 31st Mar '20 Target Set On 24th Oct '18 Implied yrs of growth (DCF) 5 Fair Value (DCF) 298 Fair Value

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone) Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 Jun-17 Oct-17 Feb-18 3QFY2018 Result Update Banking February 15, 2018 ICICI Bank Performance Highlights Particulars (` cr) 3QFY18 2QFY18 % chg (qoq) 3QFY17

More information

YES Bank. Another quarter of strong performance. Source: Company Data; PL Research

YES Bank. Another quarter of strong performance. Source: Company Data; PL Research Another quarter of strong performance January 20, 2017 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91

More information

Manappuram Finance (MGFL IN) Healthy operating performance

Manappuram Finance (MGFL IN) Healthy operating performance INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Healthy operating performance INDIA BFSI Quarterly Update Top takeaways from Q2FY19 Operating results ahead of expectations with NII/PAT at Rs

More information

Cera Sanitaryware Ltd.

Cera Sanitaryware Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 3,322 Target Price (Rs) 3,538 Target Date 31st Mar'19 Target Set On 06th Nov'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 2,447 Fair

More information

Margin boost through non-core book

Margin boost through non-core book INDUSTRY NBFCs CMP (as on 26 Apr 2017) Rs 676 Target Price Rs 600 Nifty 9,352 Sensex 30,133 KEY STOCK DATA Bloomberg LICHF IN No. of Shares (mn) 505 MCap (Rs bn) / ($ mn) 341/5,319 6m avg traded value

More information

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date

Minda Industries Equirus All rights reserved Rating Information Price (Rs) 1,032 Target Price (Rs) 1,116 Target Date Minda Industries Absolute : ADD Relative Benchmark 2QFY18 Result: Estimate (), TP (), Rating () Regular Coverage 8% ATR in 14 Months Futuristic product portfolio to drive strong growth maintain ADD Auto

More information

Punjab National Bank

Punjab National Bank Asset quality worries intensifies May 08, 2015 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating Reduce Price Rs146 Target Price Rs155 Implied

More information

Punjab National Bank

Punjab National Bank Asset quality under acute stress February 09, 2016 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating Reduce Price Rs88 Target Price Rs65 Implied

More information

LIC Housing Finance Ltd

LIC Housing Finance Ltd 4 Recommendation BUY In line results; asset quality improves CMP (27/4/215) Rs. 421 Target Price Rs. 518 Sector Stock Details Housing Finance BSE Code 5253 NSE Code Bloomberg Code LICHSGFIN LICF IN Market

More information

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart 3QFY2017 Result Update HFC January 17, 2017 LIC Housing Finance Performance Highlights Particulars (` cr) 3QFY17 2QFY17 % chg (qoq) 3QFY16 % chg (yoy) NII 915 866 5.7 747 22.6 Pre-prov. profit 811 791

More information

Persistent Systems Ltd.

Persistent Systems Ltd. 2016 Equirus All rights reserved Rating Information Price (Rs) 666 Target Price (Rs) 645 Target Date 30th Sep '17 Target Set On 25th July '16 Implied yrs of growth (DCF) 5 Fair Value (DCF) 644 Fair Value

More information

Finolex Industries Ltd.

Finolex Industries Ltd. Finolex Industries Ltd. Absolute: LONG Relative: OVERWEIGHT 2QFY19 Results: Estimates ( ), TP ( ), Rating ( ) Regular Coverage 24% ATR in 17 Months Beat driven by outperformance in PVC resin maintain LONG

More information

Reliance Industries Ltd

Reliance Industries Ltd 217Equirus All rights reserved Rating Information Price (Rs) 1,13 Target Price (Rs) 1,188 Target Date Target Set On Implied yrs of growth (DCF) 15 Fair Value (DCF) 812 Fair Value (DDM) 221 Ind Benchmark

More information

Repco Home Finance REPCO IN

Repco Home Finance REPCO IN 11 August 2014 Price: `431 India Banking & Financial Services Company Update BUY Repco Home Finance REPCO IN 12m Price Target: `460 Steady quarter REPCO reported 1Q15 net profit at `248mn, up 11% YoY and

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight 4QFY16 Results: Estimate (Ø), TP ( ), Rating ( ) Regular Coverage -8% ATR in 14 months Quarter Misses estimates; Muted earnings growth ahead

More information

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308 1QFY18 Result Update July 18, 217 Upside/ (Downside) 12 Market Cap. (Rs bn) 61 Free Float 84 Shares O/S (mn) 38 Healthy Core Operating Performance on Key Metrics; Maintain has posted a higher-than-estimated

More information

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone) Jul-15 Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 1QFY2019 Result Update Banking July 30, 2018 ICICI Bank Performance Highlights Particulars (` cr) 3QFY18 2QFY18 % chg (qoq) 3QFY17

More information

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart Apr-16 Sep-16 Feb-17 Jul-17 Dec-17 May-18 Oct-18 Mar-19 Q4FY2019 Result Update Banking Apr 22, 2019 HDFC Bank Operating performance strong; improved NIM Particulars (` cr) Q4FY19 Q3FY19 % chg (qoq) Q4FY18

More information

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190 Q4 hurt by MFI business Q4FY17 was subdued due to moderation in AUM growth, significant decline in margin and further deterioration in headline asset quality. Additionally, higher operating expenses (due

More information

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INDIA BFSI Quarterly Update Top takeaways from Q1FY19 Operating results inline

More information

Kajaria Ceramics Ltd.

Kajaria Ceramics Ltd. 2017 Equirus All rights reserved Rating Information Price (Rs) 676 Target Price (Rs) 714 Target Date 30th Sep'18 Target Set On 21st May'17 Implied yrs of growth (DCF) 15 Fair Value (DCF) 410 Fair Value

More information

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14.

VIP IndustriesLtd. Change in Estimates: Rs. Mn FY19E Chg (%) FY20E Chg (%) Sales 17,916 4% 21,129 6% EBITDA 2,572-3% 3,109-1% EPS % 14. VIP IndustriesLtd. Absolute : LONG Relative : BENCHMARK 2QFY19 Result: Estimate(), TP(), Rating() Regular Coverage 17% ATR in 14months Volume growth momentum continues, demand outlook stays robust upgrade

More information

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research 3QFY19 Result Update January 17, 219 Market Cap. (Rs bn) 56 Free Float 85 Shares O/S (mn) 39 Improving Capital Consumption to Aid Returns; Maintain continued to deliver a stable set of numbers in 3QFY19

More information

ICICI Bank. Source: Company Data; PL Research

ICICI Bank. Source: Company Data; PL Research Steady quarter, margin outlook seems more than cautious January 25, 2011 Abhijit Majumder abhijitmajumder@plindia.com +91 22 66322236 Umang Shah umangshah@plindia.com +91 22 66322242 Rating BUY Price Rs1,084

More information

Cadila Healthcare Ltd.

Cadila Healthcare Ltd. Cadila Healthcare Ltd. Absolute : Short Relative : Underweight Update Note: Estimate ( ), TP ( ), Rating ( ) Regular Coverage -7% ATR in 12 months USFDA raises concern in recently approved Sez facility

More information

and continue to build the same in future. Source: Company Data; PL Research

and continue to build the same in future. Source: Company Data; PL Research Muted performance; balance sheet transition continues January 30, 2015 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating Accumulate Price Rs172

More information

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E Weak P&L performance, good b/s show PFC reported a disappointing P&L performance with Q3 PAT at Rs 16 bn (down 17.7% YoY; our est. Rs 18.6 bn), primarily led by sharp decline in NIM (down 35 bps QoQ at

More information

Petronet LNG Ltd. Change in Estimates:

Petronet LNG Ltd. Change in Estimates: 217 Equirus All rights reserved Rating Information Price (Rs) 27 Target Price (Rs) Target Date 31st Mar'19 Target Set On 9th Nov'17 Implied yrs of growth (DCF) 2 Fair Value (DCF) Fair Value (DDM) 61 Ind

More information

HDFC Bank. Remains strong in all areas. Source: Company Data; PL Research

HDFC Bank. Remains strong in all areas. Source: Company Data; PL Research Remains strong in all areas January 20, 2018 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91 22 66322258

More information

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking. 3QFY2011 Result Update Banking January 21, 2011 Punjab National Bank Performance Highlights Particulars (` cr) 3QFY11 2QFY11 % chg (qoq) 3QFY10 % chg (yoy) NII 3,203 2,977 7.6 2,329 37.5 Pre-prov. profit

More information

South Indian Bank. Source: Company Data; PL Research

South Indian Bank. Source: Company Data; PL Research On track; one off provisions impact earnings October 11, 2017 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Vidhi Shah vidhishah@plindia.com

More information

L&T Finance Holdings

L&T Finance Holdings Revenues broadly in line; asset quality impairment seasonal July 23, 2015 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating BUY Price Rs72 Target

More information

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 Jun-17 Oct-17 Feb-18 Jun-18 Oct-18 Q2FY2019 Result Update Banking Oct 20, 2018 HDFC Bank Performance Highlights Particulars (` cr) Q2FY19 Q1FY19 % chg (qoq) Q2FY18 %

More information

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM

lower realizations resulted in revenue growth of 9% yoy. Management during the AGM 2016EquirusAll rights reserved Rating Information Price (Rs) 1,922 Target Price (Rs) 2,147 Target Date 31stMar 17 Target Set On 31st July'16 Implied yrs of growth (DCF) 10 Fair Value (DCF) 1,509 Fair Value

More information

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update Edelweiss Investment Research Ujjivan Financial Services Ltd.: Q3FY18 Result Update Good show; Robust outlook Ujjivan Financial Services Ltd. (UFS) reported a mixed set of numbers in its Q3FY18 financial

More information

Repco Home Finance Ltd.

Repco Home Finance Ltd. Housing Finance Company Repco Home Finance Ltd. Result Update Accumulate Asset quality deteriorates sharply; expect some pull back in QFY17 Institutional Research CMP (Rs) 2 Target (Rs) 7 Nifty:,72; Sensex:

More information

L&T Finance Holdings

L&T Finance Holdings Steady quarter; return ratios to improve July 25, 2016 R Sreesankar rsreesankar@plindia.com / +91 22 66322214 Pritesh Bumb priteshbumb@plindia.com / +91 22 66322232 Vidhi Shah vidhishah@plindia.com / +91

More information

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 160. ICICI BANK Ltd. Feb. 08, 2018 BSE Code: 532174 NSE Code: ICICIBANK Reuters Code:

More information

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Volume No.. III Issue No. 188. Axis Bank Ltd. October 08, 2018 BSE Code: 532215 NSE Code: AXISBANK Reuters Code:

More information

Shriram Transport Finance (SHTF IN)

Shriram Transport Finance (SHTF IN) (SHTF IN) Rating: BUY CMP: Rs1,411 TP: Rs1,787 July 25, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price

More information

M&M Financial Services (MMFSL)

M&M Financial Services (MMFSL) April 27, 2011 Result Update KEY DATA Market Cap (INR bn) 79.9 Market Cap (USD mn) 1815.3 52 WK High / Low 913 / 398 Avg Daily Volume (BSE) 83432 Face Value (INR) 10 BSE Sensex 19545 Nifty 5868 BSE Code

More information

Karur Vysya Bank (KVB) KVB IN; KVB.BO

Karur Vysya Bank (KVB) KVB IN; KVB.BO Banking India (KVB) KVB IN; KVB.BO Institutional Equity Research May 2, 2015 result review HOLD Consolidating growth, high capital, elevated slippages Current price (30 Apr) Rs 482 Target price Rs 560

More information